News

CENTOGENE GmbH (CENTOGENE) has been working together for years with local, national, and international partners in developing biomarkers to be used in…

The ‘Rare Disease Day’ is celebrated every February, to help raise awareness and build community for all those affected by rare genetic diseases.

Our new headquarter in Rostock, CentoNew, is growing rapidly – we started the countdown to our move-in November 2017.

The new headquarter in Rostock…

CENTOGENE GmbH (CENTOGENE) and Genetic Associates announce their strategic collaboration for the Australian/New Zealand market for offering high-end…

The Accreditation Committee of the College of American Pathologists has renewed accreditation to CENTOGENE AG based on results of a recent on-site…

Dr. Arndt Rolfs, CEO CENTOGENE, presented at JP Morgan Healthcare Conference 2017 about CENTOGENE's self-amplifying business model - diagnostics,…

For the first time, ever, the Parkinson’s Institute and Clinical Center and CENTOGENE have entered into a collaboration aimed at genetic screening of…

Arndt Rolfs, CEO and founder of CENTOGENE, will present the company’s business model on Wednesday, January 11, 2017, at 4:30 pm PST.

CENTOGENE announces today a new sequencing facility for rare hereditary disorders, which will use Illumina’s HiSeq X® sequencer.

The “Deutschlandstipendium” is a scholarship that helps support gifted and talented students enrolled at German universities that are public…